Nora Lozar

Inprentus has officially completed its Series A Round, raising $2.5 Million with help from investors like Flyover Capital, Serra Ventures, and other new investors. This money will help Inprentus to aggressively pursue new business in both its current synchrotron market and explore options in new markets. Inprentus has recently commercialized it’s advanced marketing process that involves a nano-scale scribing technology that creates high precision pattering of surfaces, which proves useful in x-ray and EUV experiments at synchrotron facilities and scientific research institutions by helping those scientists discover and characterize new material properties in life science, engineering and physics research. The company is currently manufacturing and fulfilling orders, and can now focus on more revenue growth with current products and expansion into adjacent markets. “Inprentus has proven it is on track to grow revenue and reach its goals,” said Flyover Capital General Partner, Keith Molzer. Read the full story on the PR Web website.

HeyGears, an EnterpriseWorks student startup graduate, is building a 3D printing Research and Development facility in Guangdong, China. Formerly OmniEars, the company has created a range of five different in-ear products of wearable technology that operate through Bluetooth. While working at EnterpriseWorks, HeyGears was partially sponsored by the iFoundry program and graduated from the incubator in 2015. HeyGears now operates out of Guangzhou, China. To learn more about HeyGears and their new facility, click here.

Trudy Kriven, CEO of EnterpriseWorks Affiliate startup KeaneTech, talks with the News-Gazette about its Small Business Innovation Research grant from the Army Corps of Engineers, geopolymer materials, and the opportunities and challenges of having a technology transition company. Kriven’s group philosophy with her company and partners is to nurture each other in a way that encourages every individual to their fullest potential, which she has been able to foster at EnterpriseWorks. Kriven shares that EnterpriseWorks, “is a very valuable asset and resource to this community, to nurture and guide start-up companies.” To read more about Trudy Kriven and KeaneTech, click here.

Aptimmune Biologics, Inc. once again breaks through industry barriers by commercializing the first inactivated musosal vaccine for Influenza A virus in swine, administered via nasal spray. This vaccine helps provide veternarians and swine producers a new way to combat these diseases that can create costly and horrific results as they spread through swine. The vaccine is safe to use, and accurately manages these respirtatory diseases. The new vaccine is available in 250-mL and 500-mL bottles, an Aptimmune recommends the swine be vaccinated once at 7-10 days old and then again during weaning, at 3-4 weeks of age. Aptimmune Biologics is a startup located at EnterpriseWorks that specializes in developing and marketing a portfolio of revolutionary musosal vaccines that provide answers for the most costly viral diseases that impact swine industry. Read more here.